ADAPTIMMUNE THERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.07% for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2017-03-13
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-03-31 was 1.07%, a 1.83% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-03-31 was 1.09%.
- ADAPTIMMUNE THERAPEUTICS PLC share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 1.73%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|
| 2016-03-31 | 1.07% 10-Q · filed 2016-05-12 | |
| 2015-03-31 | 1.09% 10-Q · filed 2016-05-12 | |
| 2014-06-30 | 1.73% 10-K · filed 2017-03-13 | |
| 2013-06-30 | 0.89% 8-K · filed 2016-07-08 |